Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Skeletal muscle mass in female athletes: The average and the extremes.

Abe T, Wong V, Dankel SJ, Bell ZW, Spitz RW, Viana RB, Loenneke JP.

Am J Hum Biol. 2019 Nov 21:e23333. doi: 10.1002/ajhb.23333. [Epub ahead of print]

PMID:
31750989
2.

Letter to the Editor Regarding Vaping Article.

Spitz RY.

Rambam Maimonides Med J. 2019 Oct 29;10(4). doi: 10.5041/RMMJ.10380. No abstract available.

3.

The contraction history of the muscle and strength change: lessons learned from unilateral training models.

Bell ZW, Wong V, Spitz RW, Chatakondi RN, Viana R, Abe T, Loenneke JP.

Physiol Meas. 2019 Oct 25. doi: 10.1088/1361-6579/ab516c. [Epub ahead of print]

PMID:
31652423
4.

The Perceived Tightness Scale Does Not Provide Reliable Estimates of Blood Flow Restriction Pressure.

Bell ZW, Dankel SJ, Spitz RW, Chatakondi RN, Abe T, Loenneke JP.

J Sport Rehabil. 2019 Sep 24:1-3. doi: 10.1123/jsr.2018-0439. [Epub ahead of print]

PMID:
31553951
5.

Assessing differential responders and mean changes in muscle size, strength, and the cross-over effect to two distinct resistance training protocols.

Dankel SJ, Bell ZW, Spitz RW, Wong V, Viana RB, Chatakondi RN, Buckner SL, Jessee MB, Mattocks KT, Mouser JG, Abe T, Loenneke JP.

Appl Physiol Nutr Metab. 2019 Sep 25. doi: 10.1139/apnm-2019-0470. [Epub ahead of print]

PMID:
31553889
6.

Red Spinach Extract Supplementation Improves Cycle Time Trial Performance in Recreationally Active Men and Women.

Gonzalez AM, Accetta MR, Spitz RW, Mangine GT, Ghigiarelli JJ, Sell KM.

J Strength Cond Res. 2019 May 24. doi: 10.1519/JSC.0000000000003173. [Epub ahead of print]

PMID:
31136549
7.

Agreement between the Open Barbell and Tendo Linear Position Transducers for Monitoring Barbell Velocity during Resistance Exercise.

Gonzalez AM, Mangine GT, Spitz RW, Ghigiarelli JJ, Sell KM.

Sports (Basel). 2019 May 23;7(5). pii: E125. doi: 10.3390/sports7050125.

8.

Longitudinal associations between changes in body composition and changes in sprint performance in elite female sprinters.

Abe T, Kawamoto K, Dankel SJ, Bell ZW, Spitz RW, Wong V, Loenneke JP.

Eur J Sport Sci. 2019 May 20:1-6. doi: 10.1080/17461391.2019.1612950. [Epub ahead of print]

PMID:
31109250
9.

Ultrasound and MRI measured changes in muscle mass gives different estimates but similar conclusions: a Bayesian approach.

Loenneke JP, Dankel SJ, Bell ZW, Spitz RW, Abe T, Yasuda T.

Eur J Clin Nutr. 2019 Aug;73(8):1203-1205. doi: 10.1038/s41430-019-0431-z. Epub 2019 Apr 23.

PMID:
31015562
10.

The impact of cuff width and biological sex on cuff preference and the perceived discomfort to blood-flow-restricted arm exercise.

Spitz RW, Chatakondi RN, Bell ZW, Wong V, Dankel SJ, Abe T, Loenneke JP.

Physiol Meas. 2019 Jun 4;40(5):055001. doi: 10.1088/1361-6579/ab1787.

PMID:
30965312
11.

The influence of biological sex and cuff width on muscle swelling, echo intensity, and the fatigue response to blood flow restricted exercise.

Wong V, Abe T, Chatakondi RN, Bell ZW, Spitz RW, Dankel SJ, Loenneke JP.

J Sports Sci. 2019 Aug;37(16):1865-1873. doi: 10.1080/02640414.2019.1599316. Epub 2019 Apr 4.

PMID:
30945606
12.

Impact of Acute Fluid Retention on Ultrasound Echo Intensity.

Dankel SJ, Abe T, Spitz RW, Viana R, Bell ZW, Wong V, Chatakondi RN, Loenneke JP.

J Clin Densitom. 2019 Mar 2. pii: S1094-6950(19)30045-9. doi: 10.1016/j.jocd.2019.02.008. [Epub ahead of print] No abstract available.

PMID:
30910401
13.

Load-Velocity Relationships of the Back vs. Front Squat Exercises in Resistance-Trained Men.

Spitz RW, Gonzalez AM, Ghigiarelli JJ, Sell KM, Mangine GT.

J Strength Cond Res. 2019 Feb;33(2):301-306. doi: 10.1519/JSC.0000000000002962.

PMID:
30688871
14.

The Water-Fat Separation Method for Determining the Fat-free Component of Subcutaneous Adipose Tissue in Humans: A Brief Review.

Abe T, Bell ZW, Dankel SJ, Wong V, Spitz RW, Loenneke JP.

J Clin Densitom. 2018 Dec 22. pii: S1094-6950(18)30198-7. doi: 10.1016/j.jocd.2018.12.007. [Epub ahead of print] Review.

PMID:
30679114
15.

Effect of Multi-Ingredient Supplement Containing Satiereal, Naringin, and Vitamin D on Body Composition, Mood, and Satiety in Overweight Adults.

Gonzalez AM, Sell KM, Ghigiarelli JJ, Spitz RW, Accetta MR, Mangine GT.

J Diet Suppl. 2018 Nov 2;15(6):965-976. doi: 10.1080/19390211.2017.1407385. Epub 2018 Jan 16.

PMID:
29336628
16.

Acute Effect of Citrulline Malate Supplementation on Upper-Body Resistance Exercise Performance in Recreationally Resistance-Trained Men.

Gonzalez AM, Spitz RW, Ghigiarelli JJ, Sell KM, Mangine GT.

J Strength Cond Res. 2018 Nov;32(11):3088-3094. doi: 10.1519/JSC.0000000000002373.

PMID:
29210953
17.

Postablation Endometrial Carcinoma.

Wortman M, Vilos GA, Vilos AG, Abu-Rafea B, Dwyer W, Spitz R.

JSLS. 2017 Apr-Jun;21(2). pii: e2017.00011. doi: 10.4293/JSLS.2017.00011. Review.

18.

Perceived function and physical performance are associated with pain and fatigue in women with fibromyalgia.

Dailey DL, Frey Law LA, Vance CG, Rakel BA, Merriwether EN, Darghosian L, Golchha M, Geasland KM, Spitz R, Crofford LJ, Sluka KA.

Arthritis Res Ther. 2016 Mar 16;18:68. doi: 10.1186/s13075-016-0954-9.

19.

Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma.

Theissen J, Oberthuer A, Hombach A, Volland R, Hertwig F, Fischer M, Spitz R, Zapatka M, Brors B, Ortmann M, Simon T, Hero B, Berthold F.

Genes Chromosomes Cancer. 2014 Aug;53(8):639-49. doi: 10.1002/gcc.22174. Epub 2014 Apr 15.

PMID:
24737690
20.

Using goal analysis to drive improvements in performance and outcomes.

Lawlor D, Spitz R, York M, Harvey B.

J Intellect Disabil. 2013 Dec;17(4):301-13. doi: 10.1177/1744629513503590. Epub 2013 Sep 5.

PMID:
24008695
21.

Aqueous dispersions of nonspherical polyethylene nanoparticles from free-radical polymerization under mild conditions.

Grau E, Dugas PY, Broyer JP, Boisson C, Spitz R, Monteil V.

Angew Chem Int Ed Engl. 2010 Sep 10;49(38):6810-2. doi: 10.1002/anie.201001800. No abstract available.

PMID:
20715232
22.

Supercritical behavior in free radical polymerization of ethylene in the medium pressure range.

Grau E, Broyer JP, Boisson C, Spitz R, Monteil V.

Phys Chem Chem Phys. 2010 Oct 7;12(37):11665-9. doi: 10.1039/c004447d. Epub 2010 Aug 16.

PMID:
20714495
23.

Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q.

Fischer M, Bauer T, Oberthür A, Hero B, Theissen J, Ehrich M, Spitz R, Eils R, Westermann F, Brors B, König R, Berthold F.

Oncogene. 2010 Feb 11;29(6):865-75. doi: 10.1038/onc.2009.390. Epub 2009 Nov 9.

PMID:
19901960
24.

The anaesthetic report: custom-made printouts from anaesthesia-information-management-systems using extensible stylesheet language transformation.

Meyer-Bender A, Spitz R, Pollwein B.

J Clin Monit Comput. 2010 Feb;24(1):51-60. doi: 10.1007/s10877-009-9209-5. Epub 2009 Nov 7.

PMID:
19898945
25.

Gains of stopping smoking: portraits of the dialogue between public health promotion, art and design.

Szklo AS, Coutinho ES, Spitz R, Gamba N Jr.

Int J Epidemiol. 2009 Dec;38(6):1459-63. doi: 10.1093/ije/dyp251. Epub 2009 Jul 13. No abstract available.

PMID:
19596748
26.

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A, Schleiermacher G, Speleman F, Spitz R, London WB, Cohn SL, Pearson AD, Maris JM.

Br J Cancer. 2009 May 5;100(9):1471-82. doi: 10.1038/sj.bjc.6605014.

27.

Heterogeneity of the MYCN oncogene in neuroblastoma.

Theissen J, Boensch M, Spitz R, Betts D, Stegmaier S, Christiansen H, Niggli F, Schilling F, Schwab M, Simon T, Westermann F, Berthold F, Hero B.

Clin Cancer Res. 2009 Mar 15;15(6):2085-90. doi: 10.1158/1078-0432.CCR-08-1648. Epub 2009 Mar 10.

28.

Polyethylene building blocks by catalyzed chain growth and efficient end functionalization strategies, including click chemistry.

Briquel R, Mazzolini J, Le Bris T, Boyron O, Boisson F, Delolme F, D'Agosto F, Boisson C, Spitz R.

Angew Chem Int Ed Engl. 2008;47(48):9311-3. doi: 10.1002/anie.200804445. No abstract available.

PMID:
18972487
29.

Risk estimation of neuroblastoma patients using molecular markers.

Fischer M, Spitz R, Oberthür A, Westermann F, Berthold F.

Klin Padiatr. 2008 May-Jun;220(3):137-46. doi: 10.1055/s-2008-1065345. Review.

PMID:
18478485
30.

Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.

Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, Schwabe D, Schilling FH, Benz-Bohm G, Berthold F.

J Clin Oncol. 2008 Mar 20;26(9):1504-10. doi: 10.1200/JCO.2007.12.3349.

PMID:
18349403
31.

Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease.

Oberthuer A, Warnat P, Kahlert Y, Westermann F, Spitz R, Brors B, Hero B, Eils R, Schwab M, Berthold F, Fischer M.

Cancer Lett. 2007 Jun 8;250(2):250-67. Epub 2006 Nov 28.

PMID:
17126996
32.

Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.

Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R, Ernestus K, König R, Haas S, Eils R, Schwab M, Brors B, Westermann F, Fischer M.

J Clin Oncol. 2006 Nov 1;24(31):5070-8.

PMID:
17075126
33.

Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome.

Spitz R, Oberthuer A, Zapatka M, Brors B, Hero B, Ernestus K, Oestreich J, Fischer M, Simon T, Berthold F.

Genes Chromosomes Cancer. 2006 Dec;45(12):1130-42.

PMID:
16958102
34.

Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.

Spitz R, Hero B, Simon T, Berthold F.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3368-73.

35.

Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.

Spitz R, Betts DR, Simon T, Boensch M, Oestreich J, Niggli FK, Ernestus K, Berthold F, Hero B.

Cancer Genet Cytogenet. 2006 May;167(1):51-6.

PMID:
16682287
36.

Versatile precursors of functional RAFT agents. Application to the synthesis of bio-related end-functionalized polymers.

Bathfield M, D'Agosto F, Spitz R, Charreyre MT, Delair T.

J Am Chem Soc. 2006 Mar 1;128(8):2546-7.

PMID:
16492033
37.

Localization of 131I-labelled monoclonal antibody ERIC1 in a subcutaneous xenograft model of neuroblastoma in SCID mice.

Otto C, Jensen M, Dietlein M, Fischer T, Schmidt M, Tawadros S, Börner SM, Weber SA, Spitz R, Bloch W, Berthold F, Schicha H, Schomäcker K.

Nucl Med Commun. 2006 Feb;27(2):171-8.

PMID:
16404231
38.

Characterization of a complex genomic alteration on chromosome 2p that leads to four alternatively spliced fusion transcripts in the neuroblastoma cell lines IMR-5, IMR-5/75 and IMR-32.

Oberthuer A, Skowron M, Spitz R, Kahlert Y, Westermann F, Mehler K, Berthold F, Fischer M.

Gene. 2005 Dec 19;363:41-50. Epub 2005 Oct 10.

PMID:
16216448
39.

Quantification of clonal hematopoiesis in polycythemia vera.

Siebolts U, Ates M, Spitz R, Thiele J, Wickenhauser C.

Virchows Arch. 2005 Dec;447(6):947-53. Epub 2005 Aug 19.

PMID:
16133363
40.

Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q.

Boensch M, Oberthuer A, Fischer M, Skowron M, Oestreich J, Berthold F, Spitz R.

Diagn Mol Pathol. 2005 Sep;14(3):177-82.

PMID:
16106200
41.

Risk estimation in localized unresectable single copy MYCN neuroblastoma by the status of chromosomes 1p and 11q.

Simon T, Spitz R, Hero B, Berthold F, Faldum A.

Cancer Lett. 2006 Jun 18;237(2):215-22. Epub 2005 Jul 12.

PMID:
16019135
42.

Alternating copolymerization of ethylene and butadiene with a neodymocene catalyst.

Thuilliez J, Monteil V, Spitz R, Boisson C.

Angew Chem Int Ed Engl. 2005 Apr 22;44(17):2593-6. No abstract available.

PMID:
15786524
43.

New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status.

Simon T, Spitz R, Faldum A, Hero B, Berthold F.

J Pediatr Hematol Oncol. 2004 Dec;26(12):791-6.

PMID:
15591897
44.

MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.

Spitz R, Hero B, Skowron M, Ernestus K, Berthold F.

Eur J Cancer. 2004 Dec;40(18):2753-9.

PMID:
15571958
45.

Genotype-environment correlations for language-related abilities: implications for typical and atypical learners.

Gilger JW, Ho HZ, Whipple AD, Spitz R.

J Learn Disabil. 2001 Nov-Dec;34(6):492-502.

PMID:
15503564
46.

Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.

Wölfl M, Jungbluth AA, Garrido F, Cabrera T, Meyen-Southard S, Spitz R, Ernestus K, Berthold F.

Cancer Immunol Immunother. 2005 Apr;54(4):400-6. Epub 2004 Sep 24.

PMID:
15449039
47.

The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome.

Oberthuer A, Hero B, Spitz R, Berthold F, Fischer M.

Clin Cancer Res. 2004 Jul 1;10(13):4307-13.

48.

Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.

Spitz R, Hero B, Ernestus K, Berthold F.

Clin Cancer Res. 2003 Oct 15;9(13):4835-40.

49.

FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.

Spitz R, Hero B, Ernestus K, Berthold F.

Med Pediatr Oncol. 2003 Jul;41(1):30-5.

PMID:
12764740
50.

Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.

Spitz R, Hero B, Ernestus K, Berthold F.

Clin Cancer Res. 2003 Jan;9(1):52-8.

Supplemental Content

Support Center